Cash Flow Statement
Growth Metrics

Opko Health (OPK) Common Equity (2016 - 2026)

Opko Health filings provide 17 years of Common Equity readings, the most recent being $1.2 billion for Q1 2026.

  • On a quarterly basis, Common Equity fell 8.16% to $1.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.2 billion, a 8.16% decrease, with the full-year FY2025 number at $1.3 billion, down 7.14% from a year prior.
  • Common Equity hit $1.2 billion in Q1 2026 for Opko Health, down from $1.3 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.7 billion in Q2 2022 to a low of $1.2 billion in Q1 2026.
  • Median Common Equity over the past 5 years was $1.4 billion (2024), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Common Equity: dropped 19.27% in 2024 and later increased 4.7% in 2025.
  • Opko Health's Common Equity stood at $1.6 billion in 2022, then decreased by 11.04% to $1.4 billion in 2023, then dropped by 1.71% to $1.4 billion in 2024, then fell by 7.14% to $1.3 billion in 2025, then decreased by 5.0% to $1.2 billion in 2026.
  • The last three reported values for Common Equity were $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025) per Business Quant data.